| ²é¿´: 746 | »Ø¸´: 0 | |||
18317190548гæ (СÓÐÃûÆø)
|
[½»Á÷]
ʵÑé²Ù×÷ | С°×µÚÒ»¿Î£¡»ù´¡Ï¸°ûÅàÑø·½·¨¼°²½Öè | MedChemExpress (MCE)
|
|
7_f4GjribL6oKPUQCJqVtpibiassFwQA.png ºÍϸ°ûµÚÒ»´Î¼ûÃæµÄʱºòÎÒÃÇÒª×öºÃʲô׼±¸ÄØ£¿¿ì¸ú×ÅСM Ò»Æð¿´¿´°É~ ▐ 01 ¼Ç¼ϸ°ûÖØÒªÐÅÏ¢ µ±µÚÒ»´ÎÔÚʵÑéÊÒ½ÓÊÕϸ°ûϵʱ£¬Óм¸ÌõÓëϸ°ûϵÓйصÄÐÅÏ¢Ó¦¸Ã±»ÕûÀíºÍ¼Ç¼£¬ÕâЩ½«È·±£Ï¸°ûϵµÄ³É¹¦·±Ö³¡¢À©Ôö¡¢Àä¶³±£´æºÍ´¢´æ¡£Ð¡ M Ç¿ÁÒ½¨ÒéÔÚϸ°ûÀ©Ôö¿ªÊ¼Ö®Ç°¼Ç¼ÒÔÏÂÐÅÏ¢£º(1) ±³¾°ÐÅÏ¢£¬(2) ´«´úÅàÑø£¬(3) Àä¶³±£´æ£¬(4) ϸ°ûϵ´¢´æ¡£ ±í 1. ÐèÒª¼Ç¼Óëϸ°ûϵÓйصÄÐÅÏ¢[1]¡£ ×¢Ò⣺ϸ°ûÅàÑøÊ±£¬Á¬ÐøÏ¸°ûϵÔÚÅàÑøÖлᷢÉú±ä»¯¡£È»¶ø£¬Ðí¶àÑо¿ÒѾ֤Ã÷Á˳¤ÆÚÅàÑø¶Ôϸ°ûϵÐÎ̬¡¢·¢ÓýºÍ»ùÒò±í´ïµÄ¸÷ÖÖÓ°Ï죺Èçϸ°ûÉú³¤±äÒ죬µ¼ÖÂϸ°ûÎÛȾµÈ¡£Òò´Ë£¬µ±µÚÒ»´Î½«Ï¸°ûϵ½ÓÊÕµ½ÊµÑéÊÒʱ£¬ÁôÓеʹ«´úµÄϸ°ûÖÖ×Ó¿âÊǷdz£ÖØÒªµÄ¡£▐ 02 ÅàÑøÏ¸°ûµÄÐÎ̬¹Û²ì¼à²âºÍ¼Ç¼ϸ°ûÐÎ̬ºÍÐÐΪÊÇÊ®·ÖÖØÒªµÄ£¬ÍƼö×ö·¨ÊÇÔÚ´«´úÅàÑøÖ®Ç°¶¨ÆÚ×ÐϸµØ¼ì²éÅàÑøÏ¸°û£¬ÒÔÈ·¶¨Æä״̬ºÍ½¡¿µ×´¿ö¡£Ï¸°ûÐÎ̬¹Û²ì½á¹û¿ÉÒÔ°ïÖú¡°¿ÆÑÐÍô¡±ÃÇÅÐ¶Ï (1) ϸ°ûµÄÐÎ̬£º½¡¿µ or ¶ñ»¯ (¼´Ë¥ÀÏ»ò»µËÀµÄϸ°û)£¿(2) ÊÇ·ñ´æÔÚϸ°ûÎÛȾ£¿(3) Çø·Öϸ°û¼°Ï¸°ûÃܶȡ£´ó¶àÊýϸ°ûÅàÑøÉú³¤Îª£ºÐü¸¡ÅàÑøºÍÌù±ÚÅàÑø¡£È»¶ø£¬ÔÚijЩÇé¿öÏ¿ÉÄÜ»á¹Û²ìµ½Ðü¸¡ºÍÌù±ÚµÄ»ìºÏȺÌå¡£ ÅàÑøÖе͝Îïϸ°ûµÄÐÎ×´¿É·ÖΪÈý¸ö»ù±¾ÐÎ̬£º³ÉÏËάϸ°ûÑù(Fibroblast-like)¡¢ÉÏÆ¤Ï¸°ûÑù(Epithelial-like) ºÍÀàÁܰÍĸϸ°ûÑù(Lymphoblastoid-like)¡£ ͼ 1. ÅàÑøÏ¸°ûµÄÒ»°ãÌØÕ÷ºÍÐÎ×´[1]¡£ (A) ÉÏÆ¤Ñù (Ìù±Ú)£»(B) ³ÉÏËάϸ°ûÑù (Ìù±Ú)£»(C) ÁܰÍĸϸ°ûÑù (Ðü¸¡Òº)¡£ 13_Q0Tk5Mv21098agAozGBnnFOpja5BLA.png (ÒÔÊÕµ½ T25 ÅàÑøÆ¿ÎªÀý) 1. Ïȹ۲ìÅàÑø»ùÑÕÉ«ÒÔ¼°ÊÇ·ñÓЩҺÇé¿ö£¬ÔÙÔÚµ¹ÖÃÏÔ΢¾µÏ¹۲ìϸ°û״̬£¬²¢¶Ôϸ°û½øÐв»Í¬±¶ÊýÅÄÕÕ£¬Åųýϸ°û±¾ÉíÎÛȾ»ò״̬²»ºÃµÄÇé¿ö£» 2. È·ÈÏϸ°û״̬Õý³£ºó½«Ï¸°ûÆ¿Íâ±ÚÏû¶¾£¬·ÅÔÚÅàÑøÏä¾²ÖÃÊýСʱ (¸ù¾Ýϸ°ûÃܶȶ¨) ÒÔÎȶ¨Ï¸°û״̬£» 3.1 Ìù±Úϸ°û£ºÏ¸°ûÉú³¤Ãܶȳ¬¹ý 80% ʱ£¬¿É¸ù¾ÝÇé¿ö´«´ú£¬Èôϸ°û䳬¹ý80%»ãºÏ¶Èʱ£¬¿É¶ÔÆäÅàÑø»ù½øÐа뻻Һ´¦Àí£¬¼´ÎüÈ¥Ò»°ëµÄÔÅàÑø»ù (²»Òª¶ªµô¿ÉÒÔÁô¸øÏ¸°û¹ý¶ÉÓÃ)£¬ÔÙ¼ÓÈëµÈÁ¿µÄÍêÈ«ÅàÑø»ù¼ÌÐøÅàÑø£¬Ö±ÖÁϸ°ûÃܶȳ¬¹ý 80% ÒÔºóÔÙ½øÐд«´ú£» 3.2 Ðü¸¡Ï¸°û£º½«Ï¸°ûÅàÑøÆ¿ÄÚÒºÌå×ªÒÆÖÁÀëÐĹܣ¬500 g ÀëÐÄ 5 min£¬ÎÂÈáµÄµ¹³öÉÏÇåÒº (Ò²¿ÉÒÔÏȱ£ÁôÏÂÀ´ÒÔ±¸²»Ê±Ö®Ðè)£¬¹Üµ×ϸ°û³Áµí¼ÓÈë 10 mL ÍêÈ«ÅàÑø»ù´µ´ò¡¢ÖØÐü¡£·ÅÈëеÄϸ°ûÅàÑøÆ¿ÖÐÅàÑø¹ýÒ¹£¬¸ù¾Ýϸ°ûÃܶȼ°Éú³¤Çé¿ö·ÖÆ¿´«´ú¡£ ͼ 2. ̨ÅÎÀ¶È¾É«Í¼[2]¡£ 4. ϸ°û¼ÆÊý£ºÎÞѪÇåÅàÑø»ù½«Ï¸°ûÐüҺϡÊ͵½ 200-2000 ¸ö/ºÁÉý£¬ÔÚ 10-100 µl µÄϸ°ûÐüÒºÖмÓÈëµÈÌå»ýµÄ 0.4% µĄ̈ÅÎÀ¶ÈÜÒº¡£ÇáÇá»ìÔÈ£¬ÓÃѪÇò¼ÆÊý°å¼ÆÊýϸ°û¡£»îϸ°ûÅųą̂ÅÎÀ¶£¬ÒÀ¾ÉÊÇ͸ÁÁµÄ״̬£¬ËÀϸ°û»á±»È¾³ÉÀ¶É«¡£ÓÐϸ°û¼ÆÊýÒǵģ¬¿ÉÖ±½ÓÓüÆÊýÒǽøÐмÆÊý¸ü·½±ãŶ~ 16_v1CRHImFBD1XGuXaHFib7icd65BHwg.png Ñ¡ÔñºÏÊʵÄÅàÑø»ù¶ÔÓÚϸ°ûÅàÑøµÄ³É¹¦ÖÁ¹ØÖØÒª£¬²»Í¬ÀàÐ͵Äϸ°û¾ßÓв»Í¬µÄÉú³¤ÐèÇóºÍÌØ¶¨µÄÅàÑøÌõ¼þ¡£Ê×ÏÈ£¬ÅàÑø»ùÖеÄÓªÑøÎïÖÊÊÇά³Öϸ°ûÉú³¤ºÍ´úлËù±ØÐèµÄ¡£²»Í¬ÀàÐ͵Äϸ°ûÐèÒª¸÷ÖÖ²»Í¬µÄ°±»ùËá¡¢ÌÇÀࡢάÉúËØ¡¢ÎÞ»úÑκÍÖ¬ÖʵÈÓªÑøÎïÖÊÒÔÂú×ãÆäÉúÀíÐèÇó¡£Èç¹ûÅàÑø»ùÖÐȱ·¦±ØÒªµÄÓªÑøÎïÖÊ£¬Ï¸°û¿ÉÄÜÎÞ·¨Õý³£Éú³¤ºÍ·ÖÁÑ£¬ÉõÖÁ»áµ¼ÖÂϸ°ûËÀÍö[3][4]¡£Ñ¡ÔñºÏÊʵÄÅàÑø»ùµÄʱºòÓÅÏȸù¾Ýϸ°ûÀ´Ô´¹«Ë¾ÌṩµÄÅàÑøÌõ¼þ£¬ÎÞ·¨È·¶¨À´Ô´µÄ¿ÉÒԲο¼ ATCC ÍÆ¼öϸ°û¶ÔÓ¦ÅàÑø»ù¡£±í 2. ³£¼ûϸ°ûµÄÅàÑøÌåϵ¡£ Æä´Î£¬²»Í¬ÀàÐ͵Äϸ°ûÐèÒªÌØ¶¨µÄÉú³¤Òò×Ӻͼ¤ËØÀ´Î¬³ÖÆäÌØ¶¨µÄ¹¦ÄܺÍÌØÐÔ¡£ÀýÈ磬Éñ¾Ï¸°ûÅàÑø»ùÖÐͨ³£Ìí¼ÓÉñ¾ÓªÑøÒò×Ó £¬ÒÔ´Ù½øÉñ¾Ï¸°ûµÄÉú³¤ºÍÍ»´¥Ðγɣ»Ì¥Å£ÑªÇå ͨ³£±»Ìí¼Óµ½ÅàÑø»ùÖУ¬Ìṩϸ°ûËùÐèµÄÉú³¤Òò×Ó¡¢µ°°×ÖÊºÍÆäËûÖØÒª×é·Ö¡£ ´ËÍ⣬±ØÒªÊ±ºòÒ²¿ÉÒÔ¼ÓÈ뿹ÉúËØÀ´·ÀÖ¹ÎÛȾ±£ÎÀϸ°û¡£ÀýÈçË«¿¹ (ÇàÃ¹ËØ/Á´Ã¹) ÉõÖÁÈý¿¹ (ÇàÃ¹ËØ¡¢Á´Ã¹ËØ¡¢Á½ÐÔÃ¹ËØ B) ÒÔÒÖÖÆÏ¸¾úºÍÕæ¾úµÈ΢ÉúÎïµÄÉú³¤£¬ÇàÃ¹ËØ-Á´Ã¹ËØ¿ÉÓÐЧÒÖÖÆ¶àÊý¸ïÀ¼ÊÏÑôÐÔ¾ú ºÍ¸ïÀ¼ÊÏÒõÐÔ¾úµÄÉú³¤£¬Á½ÐÔÃ¹ËØ B ¿ÉÓÃÓÚÒÖÖÆÕæ¾ú¡¢½ÍĸµÄÎÛȾ¡£ 18_wTZh7vJm0rPaYgic2LRvOe1gjTaXBw.png Ëæ×Åʱ¼äµÄÍÆÒÆ£¬Ï¸°ûµÄÊýÁ¿»áÔö¼Ó£¬¶ø¿Õ¼äºÍ×ÊÔ´È´ÓÐÏÞ¡£ËùÒÔ£¬µ±Ï¸°û´ïµ½Ò»¶¨ÃܶÈʱ£¬¾Í¸Ã¿¼ÂǸøËûÃÇÒ»¸ö¸ü¹ãÀ«µÄ¾Óס¿Õ¼ä£¬ÈÃËûÃǼÌÐø²ýÊ¢·±ÑÜ¡£ ͼ 3. ´«´úÁ÷³Ìͼ¡£ ³£¼ûµÄϸ°û´«´ú²½Öè²Î¿¼ÈçÏ£º (ÒÔ T25 ÅàÑøÆ¿ÎªÀý) 1. ´ÓÅàÓýÏäÖÐÈ¡³öϸ°û£¬ÏÔ΢¾µÏ¹۲ìϸ°û£¬»ãºÏ¶È´óÓÚ 80% ¼´¿É´«´ú£» 2. ×¼±¸²Ù×÷£ºÅàÑø»ùºÍ PBS ·ÅÖà 37¡æ ˮԡ¹øÔ¤ÈÈ£¬½«´«´úËùÓúIJÄ(ÒÆÒº¹Ü¡¢ÒÆÒºÇ¹¡¢T25 ÅàÑøÆ¿¡¢Ç¹Í·µÈ) ·ÅÈ볬¾»¹¤×÷̨£¬×ÏÍâÃð¾ú 30 min ºóͨ·ç£¬½«ÒÈøºÍÔ¤ÈȺóµÄÅàÑø»ùÒÔ¼° PBS Óà 75% ¾Æ¾«Ïû¶¾ºó·ÅÈ볬¾»¹¤×÷̨£» 3. ÎüÆúÅàÑøÆ¿ÄÚ¾ÉÅàÑøÒº£¬5 mL PBS Èóϴϸ°û£¬ÎüÆú PBS£» 4. ¼ÓÈë 1 mL Òȵ°°×ø£¬Çá»ÎÅàÑøÆ¿Ê¹Òȵ°°×ø³ä·Ö¸²¸Çϸ°û£¬·ÅÈë 37¡æ ÅàÑøÏäÖзõÓý 30 s-2 min (ʵ¼Ê·õÓýʱ¼äÒòËùʹÓõÄϸ°ûϵ¶øÒì)£» 5. ÏÔ΢¾µÏ¹۲죬µ± ¡Ý90% µÄϸ°ûÍÑÂäʱ£¬¼ÓÈëÁ½±¶ÒÈøÌå»ýµÄº¬ÑªÇåµÄÍêÈ«ÅàÑø»ù£¬ÖÕÖ¹Ïû»¯£¬´µ´òϸ°û²ã±íÃæÊý´Î£¬Ê¹Æä·ÖÉ¢³Éµ¥¸öϸ°û£» 6. 500¡Á g ÀëÐÄ 3-5 ·ÖÖÓ£¬½«Ï¸°û³ÁµíÖØÐüÓÚº¬ÑªÇåµÄÍêÈ«ÅàÑø»ù£» 7. ½«Ï¸°ûÐüÒº°´´«´ú±ÈÀý·Ö×°µ½ÅàÑøÆ¿£¬²¹³äÐÂÏÊÍêÈ«ÅàÑø»ù£¬Çá»ÎÅàÑøÆ¿Ê¹Ï¸°û·Ö²¼¾ùÔÈ£¬²¢×öºÃ±ê¼Ç£» 8. ÏÔ΢¾µÏ¹۲ìϸ°ûÃܶȼ°×´Ì¬£¬°Ñϸ°ûËÍ»ØÅàÑøÏä¡£ ×¢Ò⣺ÀûÓÃÒȵ°°×ø½øÐж¯Îïϸ°û´«´úÅàÑøÊ±ÐèÒª¿¼ÂÇÐí¶àÒòËØ¡£Òȵ°°×ø¾ßÓÐË®½âµ°°×ÖʵĻîÐÔ£¬¿ÉÓ°Ïìϸ°ûµÄ¶àÖÖÉúÀí´úл¹¦ÄÜ¡£ Tips£ºÒȵ°°×ø´«´úÅàÑøÏ¸°ûµÄ×î¼Ñ·½·¨ ÔÚÌí¼ÓÒȵ°°×ø֮ǰ£¬Óò»º¬ Ca2+ ºÍ Mg2+ µÄÉúÀíÑÎË®/PBS ÇåÏ´£¬ÒÔÈ¥³ýÕâЩÀë×Ó (ÈÜÒºÖÐµÄ Ca2+¡¢Mg2+ ºÍѪÇå»á½µµÍÒÈø»îÁ¦)£» ÓÃ×îµÍŨ¶ÈºÍÌå»ýµÄÒȵ°°×ø´ÓÅàÑøÆ¿±íÃæÈ¥³ýϸ°û£» Èç¹û¿ÉÄܵϰ£¬ÔÚÊÒλò¸üµÍµÄζÈÏÂʹÓÃÒȵ°°×øÈÜÒº£¬ÒÔ¼õÉÙøµÄÄÚÍÌ×÷Óã» ¾¡¿ÉÄ̵ܶÄʱ¼äʹÓÃÒȵ°°×ø´¦Àíϸ°û£¬±ÜÃâÏû»¯¹ý¶ÈÓ°Ïìϸ°û£» ÓÃÒȵ°°×øÒÖÖÆ¼ÁÈ纬ѪÇå»òѪÇåµÄÍêÈ«ÅàÑø»ùÖкÍÖÕÖ¹Òȵ°°×ø»îÐÔ£¬È»ºóÓÃÀëÐijýÈ¥Òȵ°°×ø£» ϸ°ûÍÑÂäºóÁ¢¼´ÀëÐijýÈ¥ÅàÑøÆ¿±íÃæµÄÒȵ°°×ø¡£ 21_iayL8CQ2icd1T2ADwc7Ok4YTUxVQEQ.png ϸ°û¶³´æ¾ÍÏñÊǸøÏ¸°ûÒ»¸ö±ù¶³µÄʱ¼äÂÃÐлúƱ£¬±£Ö¤ËüÃÇÔÚδÀ´¿ÉÒÔ¡°½â¶³¡±»Øµ½»îÁ¦ËÄÒçµÄ״̬¡£ÕâÒ»¹ý³Ì¿ÉÒÔÈ·±£ÄãµÄÕä¹óϸ°û¿â²»»áÒòΪʱ¼äµÄÍÆÒÆ¶øÔâÊÜËðʧ¡£ ÄÇô¶³´æÏ¸°ûµÄ×î¼Ñʱ»úÊÇʲôʱºò£¿Ê²Ã´ÑùµÄϸ°ûŨ¶ÈºÏÊÊ£¿ÒªÓöàÉÙ¶³´æÒºÄØ£¿ÔõôʵÏÖϸ°ûµÄ¡°Âý¶³¡±£¿¸´ËÕºóµÚ¶þÌì·¢ÏÖϸ°ûûÓлºÃ²»ÈÝÒ׸´ËÕµÄϸ°û¾¹È»ÎÛȾÁË£¿Ôõô²ÅÄÜÈÃϸ°ûÂúѪ¸´»îÄØ£¿ [1] Reid YA. Best practices for naming, receiving, and managing cells in culture. In Vitro Cell Dev Biol Anim. 2017 Oct;53(9):761-774. [2] Aung S M, et al. Live and dead cells counting from microscopic trypan blue staining images using thresholding and morphological operation techniques[J]. International Journal of Electrical and Computer Engineering, 2019, 9(4): 2460. [3] Jessica Cox, et al. Co-occurrence of Cell Lines, Basal Media and Supplementation in the Biomedical Research Literature. Journal of Data and Information Science. 2020, Vol. 5. Issue (3) : 161-177. [4] Lee JT, et al. Cell culture medium as an alternative to conventional simulated body fluid. Acta Biomater. 2011 Jun;7(6):2615-22. [5] Yee Y, et al. Mechanism of penicillin-streptomycin synergy for clinical isolates of viridans streptococci[J]. The Journal of infectious diseases, 1986, 154(3): 531-534. [6] Baust, et al. Development and Assessment of a Novel Device for the Controlled, Dry Thawing of Cryopreserved Cell Products. BioProcessing Journal. 2016;15. 30-41. |
» ²ÂÄãϲ»¶
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖеÄȤÊ£ºÊµÑéÆ÷²ÄµÄ ¡°ÎÚÁú¡±
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖеÄȤÊ£ººÍʵÑé²ÄÁ쵀 ¡°¶·ÖǶ·Ó¡±
ÒѾÓÐ0È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ188È˻ظ´
µ°°×Öʼì²â£º¾«×¼·ÖÎö£¬½âËøÉúÎï·Ö×ÓµÄÃÜÂë
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑé֮СÊóʵÑ飺ÑϽ÷Éè¼Æ£¬½âÎöÉúÃü»úÖÆµÄÖØÒªÔØÌå
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®ÖØ½ðÊô¼ì²â£º¾«×¼É¸²é£¬ÊØ»¤½¡¿µÓë»·¾³µÄ·ÀÏß
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®¡°ÍܲâÖØ½ðÊôÎÒ±³¹øÈýǧ¡±
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®¡°ÊóÌÓÈý´ÎÎÒ·¢ÈýƪSCI¡±
ÒѾÓÐ0È˻ظ´
ÄÉÃ×Á£¶È·ÖÎö
ÒѾÓÐ3È˻ظ´
ÁÖ¿ÆÔºÁÖ»¯ËùÕÐÊÕ²ÄÁÏÓ뻯¹¤×¨ÒµË¶Ê¿£¬×ø±êÄϾ©
ÒѾÓÐ0È˻ظ´













»Ø¸´´ËÂ¥